CryoTherapeutics
Founded 2009 · 25 employees on LinkedIn · 1 known investors
CryoTherapeutics develops a catheter-based cryotherapy system, consisting of a console and an intracoronary balloon catheter, used by interventional cardiologists to stabilize vulnerable atherosclerotic plaques and reduce the risk of heart attack. The implant-free technology cools plaque to between -10°C and -20°C to reduce inflammation and thicken the fibrous cap, lowering rupture risk.
Investors · 1
In the news
Frequently asked questions
- What does CryoTherapeutics do?
- CryoTherapeutics develops a catheter-based cryotherapy system, consisting of a console and an intracoronary balloon catheter, used by interventional cardiologists to stabilize vulnerable atherosclerotic plaques and reduce the risk of heart attack. The implant-free technology cools plaque to between -10°C and -20°C to reduce inflammation and thicken the fibrous cap, lowering rupture risk.
- Who are CryoTherapeutics's investors?
- CryoTherapeutics's investors include Creathor Ventures.